UBS Group AG - XTANT MED HLDGS INC ownership

XTANT MED HLDGS INC's ticker is XTNT and the CUSIP is 98420P308. A total of 19 filers reported holding XTANT MED HLDGS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of XTANT MED HLDGS INC
ValueSharesWeighting
Q3 2023$4,641
+3.2%
4,219
-40.3%
0.00%
Q1 2023$4,499
+404.4%
7,063
+422.8%
0.00%
Q4 2022$892
-70.3%
1,351
-72.4%
0.00%
Q2 2022$3,000
-88.0%
4,888
-89.1%
0.00%
Q4 2021$25,000
+1150.0%
44,720
+3443.6%
0.00%
Q4 2020$2,000
+100.0%
1,262
+7.5%
0.00%
Q2 2020$1,000
-85.7%
1,174
-89.4%
0.00%
Q1 2020$7,000
+133.3%
11,088
+487.6%
0.00%
Q4 2018$3,0000.0%1,887
+159.2%
0.00%
Q3 2018$3,000
-93.6%
728
-91.4%
0.00%
Q2 2018$47,000
+56.7%
8,452
+120.0%
0.00%
Q1 2018$30,0003,8410.00%
Other shareholders
XTANT MED HLDGS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Altium Capital Management LP 8,292,602$13,517,0003.14%
Orbimed Advisors 72,873,494$118,784,0001.20%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 290,902$474,0000.01%
Virtu Financial LLC 36,613$60,0000.01%
Renaissance Technologies 1,012,000$1,650,0000.00%
BANK OF AMERICA CORP /DE/ 72$00.00%
WELLS FARGO & COMPANY/MN 28$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 21,204$34,0000.00%
STATE STREET CORP 22,800$37,0000.00%
View complete list of XTANT MED HLDGS INC shareholders